Professor Andrew Rowland
Professor in Clinical Pharmacology
College of Medicine and Public Health
I am passionate about engaging with industry and clinicians to resolve knowledge gaps regarding the impact of life stage, environmental factors and disease on the activity of proteins that influence drug exposure and response. My research focusses on using this knowledge to inform safe and effective use of medicines to achieve optimal therapeutic outcomes for patients. I strive to be a role model for courage, integrity and perseverence to my two sons.
I was awarded a PhD in Clinical Pharmacology from Flinders University in 2009. Following a 2 year post-doctoral position in the Miners’ Drug Metabolism laboratory, in 2011 I was appointed to my current academic position in the College of Medicine and Public Health. Now Associate Professor, I lead a dynamic team of researchers at the forefront of advancing extracellular vesicle (EVs) isolation and analysis platforms for use with biospecimens. My team are world leaders in the isolation and characterisation of tissue specific EVs from blood and work closely with industry and clinicians to apply this technology to improve patient outcomes by enhancing drug efficacy and minimising harms.
I teach the principles of pharmacology and therapeutics to a spectrum of medical and health professionals including doctors, nurse prescribers, paramedics and medical scientists.
2004 - BSc Hons (Pharmacology) - Flinders University
Awards:
2019 - Beat Cancer Mid-Career Research Fellowship
2017 - ASCEPT / Certara New Investigator Award
2013 - Flinders University Vice Chancellor's Award for Early Career Researchers
External Grant Funding:
I have led successful Category 1 national and international competitive research applications totaling in excess of $8 million. Recent major grants include:
2023 - AstraZeneca - $170,000
Principal Investigator - International Industry Funding
2022 - Pfizer Worldwide Research and Development - $340,000
Principal Investigator - International Industry Funding
2022 - Boehringer Ingelheim - $80,000
Principal Investigator - International Industry Funding
2021 - Pfizer Worldwide Research and Development - $391,000
Chief Investigator A - International Industry Funding
2019 - Cancer Council Mid-Career Research Fellowship - $600,000
Fellowship - National Competitive Funding
2018 - NHMRC Project Grant - $731,812
Chief Investigator A - National Competitive Funding
2018 - Pfizer Worldwide Research and Development - $340,000
Principal Investigator - International Industry Funding
I actively engage with innovative formats for teaching clinical and experimental pharmacology to students across many courses and degrees within the College of Medicine and Public Health at Flinders University.
I am also involved in the ongoing education and training of Paramedics, Doctors and Nurse Practitioners, and supervise post graduate (Honours and PhD) and graduate medical research (MD) students within this faculty.
2019 Simcyp Most Informative Scientific Report - AUG 2019
2019 British Journal of Clinical Pharmacology Prize - NOV 2019
2015 ASCEPT Drug Disposition and Response Prize - DEC 2015
2019 Drug Disposition and Response Prize - NOV 2019
Current Professional Memberships
- American Society for Pharmacology and Experimental Therapeutics
- Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT)
- National Health and Medical Research Council (NHMRC) Research Translation Faculty
- European Society of Medical Oncology (ESMO)
- International Society for the Study of Xenobiotics (ISSX)
- Adelaide Pharmacology Group (APG)
Recent External Professional Activities
- Board of Directors for ASCEPT (2022 – current)
- Communications officer ASPET Division of Drug Metabolist and Disposition (2021 – current)
- ASPET Executive Committee (2021 – current)
- Chair of ANZSEV scientific meeting organizing committee (ANZSEV 2023)
- Member and Session Chair ISSX scientific meeting organizing committee (AP-ISSX 2023)
- Chair ASCEPT Drug Disposition and Response (DDR) Special Interest Group (2012 - 2016)
- Editorial board member for the journals Therapeutic Advances in Drug Safety and Translational Cancer Research.
- Manuscript reviewer for journals including Annals of Internal Medicine, British Journal of Clinical Pharmacology, Clinical Pharmacology and Therapeutics, Drug Metabolism and Disposition, Drug Metabolism and Pharmacokinetics, JAMA Oncology and Oncotargets.
- Grant reviewer for organisations including the NHMRC Australia, New Zealand Ministry of Science and Innovation and Diabetes Australia Research Trust.
- Pharmacology
- Precision Medicine
Sturt Rd, Bedford Park
South Australia 5042
South Australia | Northern Territory
Global | Online
Follow Flinders
